Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Patient Preference and Adherence
|
March 23, 2011
Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis
Rachel Halpern, Sonalee Agarwal, Carole Dembek, et al.
Advances in Therapy
|
August 27, 2011
Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: retrospective claims analysis
Rachel Halpern, Sonalee Agarwal, Leigh Borton, et al.
International Journal of Geriatric Psychiatry
|
November 16, 2018
Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia
Rachel Halpern, Jerald Seare, Junliang Tong, et al.
Journal of Health Economics and Outcomes Research
|
September 4, 2023
Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
Mike Durkin, Jacqueline Pesa, Jessica Lopatto, et al.
Pain Practice : the Official Journal of World Institute of Pain
|
October 8, 2015
Evaluating Guideline-recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia
Rachel Halpern, Sonali N Shah, Joseph C Cappelleri, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 26, 2016
Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs
Carolyn Martin, Kevin Odell, Joseph C Cappelleri, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
May 8, 2013
Adherence associated with oral medications in the treatment of spasticity
Rachel Halpern, Patrick Gillard, Glenn D Graham, et al.
Journal of Medical Economics
|
April 28, 2020
Real-world cost of treatment for multiple sclerosis patients initiating and receiving infused disease-modifying therapies per recommended label in the United States
Jacqueline Nicholas, Rachel Halpern, Marina Ziehn, et al.
The Primary Care Companion for CNS Disorders
|
June 8, 2017
Patient Characteristics Associated With Use of Lurasidone Versus Other Atypical Antipsychotics in Patients With Bipolar Disorder: Analysis From a Claims Database in the United States
Mauricio Tohen, Daisy Ng-Mak, Krithika Rajagopalan, et al.
Current Medical Research and Opinion
|
June 3, 2009
Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis
Rachel Halpern, Reema R Mody, Mahesh J Fuldeore, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Patient Preference and Adherence
|
March 23, 2011
Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis
Rachel Halpern, Sonalee Agarwal, Carole Dembek, et al.
Advances in Therapy
|
August 27, 2011
Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: retrospective claims analysis
Rachel Halpern, Sonalee Agarwal, Leigh Borton, et al.
International Journal of Geriatric Psychiatry
|
November 16, 2018
Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia
Rachel Halpern, Jerald Seare, Junliang Tong, et al.
Journal of Health Economics and Outcomes Research
|
September 4, 2023
Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
Mike Durkin, Jacqueline Pesa, Jessica Lopatto, et al.
Pain Practice : the Official Journal of World Institute of Pain
|
October 8, 2015
Evaluating Guideline-recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia
Rachel Halpern, Sonali N Shah, Joseph C Cappelleri, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 26, 2016
Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs
Carolyn Martin, Kevin Odell, Joseph C Cappelleri, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
May 8, 2013
Adherence associated with oral medications in the treatment of spasticity
Rachel Halpern, Patrick Gillard, Glenn D Graham, et al.
Journal of Medical Economics
|
April 28, 2020
Real-world cost of treatment for multiple sclerosis patients initiating and receiving infused disease-modifying therapies per recommended label in the United States
Jacqueline Nicholas, Rachel Halpern, Marina Ziehn, et al.
The Primary Care Companion for CNS Disorders
|
June 8, 2017
Patient Characteristics Associated With Use of Lurasidone Versus Other Atypical Antipsychotics in Patients With Bipolar Disorder: Analysis From a Claims Database in the United States
Mauricio Tohen, Daisy Ng-Mak, Krithika Rajagopalan, et al.
Current Medical Research and Opinion
|
June 3, 2009
Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis
Rachel Halpern, Reema R Mody, Mahesh J Fuldeore, et al.
Page
of 4